AMZN
Amazon.com, Inc.
AMZN has lower modeled downside risk, despite its lower overall score.
AS
Amer Sports, Inc.
AS has a slight edge over AMZN overall, supported by stronger fundamentals and stronger modeled upside.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
AS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Healthy | |
| Strong |
AS's revenue, profitability, cash flow and balance sheet are all currently healthy.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
AS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 20x | $30.19 | — |
| Current | 31x | $30.19 | — |
| Cheap | 41x | $39.35 | +30% |
| Fair | 68x | $65.43 | +117% |
| Expensive | 102x | $98.18 | +225% |
Historical ranges are pointers, not guarantees.
AS has the edge over AMZN in the historical PE scenario, which offers more potential upside but is not a forecast.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
AS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Moderate | |
| Moderate |
AS has the edge over AMZN on the outlook, with more favorable valuation expectations.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN's earnings per share have climbed steadily: $12.37 over the past year, up 75% from the year before, and higher year over year for 14 quarters in a row. Its recent earnings include one-off gains.
AS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.54 | +61% |
| Q2 2026 | $0.96 | +134% |
| Q1 2026 | $0.81 | +119% |
| Q4 2025 | $0.76 | +443% |
| Q3 2025 | $0.55 | +$0.62 |
| Q2 2025 | $0.41 | +$0.66 |
| Q1 2025 | $0.37 | +$0.81 |
| Q4 2024 | $0.14 | +$0.55 |
| Q3 2024 | -$0.07 | +$0.46 |
AS's earnings per share have climbed steadily: $0.96 over the past year, up 134% from the year before, and higher year over year every quarter since mid-2024.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN's revenue has grown year over year every quarter since late 2020: $202B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over AS on profitability, with a higher operating margin.
AS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.6B | +32% |
| Q1 2026 | $1.9B | +32% |
| Q4 2025 | $2.1B | +28% |
| Q3 2025 | $1.8B | +30% |
| Q2 2025 | $1.2B | +23% |
| Q1 2025 | $1.5B | +23% |
| Q4 2024 | $1.6B | +24% |
| Q3 2024 | $1.4B | +17% |
AS has the edge over AMZN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 10% | +6.9 points |
| Q1 2026 | 16% | +1.6 points |
| Q4 2025 | 11% | -1 points |
| Q3 2025 | 12% | -0.8 points |
| Q2 2025 | 3.5% | +4.4 points |
| Q1 2025 | 15% | +5.4 points |
| Q4 2024 | 12% | +7.3 points |
| Q3 2024 | 13% | +4 points |
AS's operating margin was 10% last quarter, up 6.9 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
AS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $103.6M | +$204.4M |
| Q1 2026 | $93.9M | -23% |
| Q4 2025 | $550.7M | +65% |
| Q3 2025 | -$59.2M | +$40.6M |
| Q2 2025 | -$100.8M | -$5.1M |
| Q1 2025 | $122.6M | +128% |
| Q4 2024 | $334.7M | +31% |
| Q3 2024 | -$99.8M | -$26.1M |
AS has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over AS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
AS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.9% | +16.8M shares |
| 1 year | +5% | +28.3M shares |
| 3 years | +20% | +99.6M shares |
AS has 589M diluted shares, up 5% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
AS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.3x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.6x | Very low |
| Q4 2024 | 0.8x | Very low |
| Q2 2024 | 4.6x | High |
AS has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
AS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.6 | Neutral |
| Stochastic | 37.4 | Neutral |
AS's weekly RSI is 47 (neutral) and its Stochastic is 37 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over AS on valuation relative to its sector.
AS PE vs Consumer Cyclical Sector
| Metric | AS | Sector median | Relative |
|---|---|---|---|
| PE | 31x | 18x | 75% above |
| PE % | 3 | 25 | 22 pts below |
AS is trading at 31x earnings, a 75% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has stronger trend alignment. AMZN is above 5 of 5 weekly averages versus AS above 1 of 4.
AS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 3.9% above |
| 20 week MA | $31.3 | 3.5% below |
| 50 week MA | $34.1 | 12% below |
| 100 week MA | $33.3 | 9.3% below |
AS has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 9.3% below its 100-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over AS on returns for 2026, with the stronger performance.
AS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $15.0 | $28.4 | +90% |
| 2025 | $28.4 | $38.4 | +35% |
| 2026 YTD | $38.4 | $30.2 | -21% |
AS has finished every year since 2024 higher, and it's down 21% so far in 2026.